Is GSHRF or MRK a better dividend investment in 2026?

GSHRF currently yields 185.19% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: GSHRF offers higher current income.

What is the dividend yield difference between GSHRF and MRK?

GSHRF has a forward dividend yield of 185.19% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 181.94 percentage points.

Home › Compare › GSHRF vs MRK

GSHRF vs MRK: Dividend Comparison 2026

GSHRF yields 185.19% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GSHRF wins by $76.97M in total portfolio value

INVESTMENT

TIME HORIZON10 years

GSHRF

● Live price

185.19%

Share price

$1.08

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$77.00M

Annual income

$37,339,999.80

Full GSHRF calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — GSHRF vs MRK

📍 GSHRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GSHRF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GSHRF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GSHRF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GSHRF

Annual income on $10K today (after 15% tax)

$15,740.74/yr

After 10yr DRIP, annual income (after tax)

$31,738,999.83/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, GSHRF beats the other by $31,738,192.08/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GSHRF + MRK for your $10,000?

GSHRF: 50%MRK: 50%

100% MRK50/50100% GSHRF

Portfolio after 10yr

$38.52M

Annual income

$18,670,475.05/yr

Blended yield

48.47%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GSHRF

No analyst data

Altman Z

21.1

Piotroski

1/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GSHRF buys

MRK buys

No recent congressional trades found for GSHRF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGSHRFMRK

Forward yield	185.19% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$77.00M ✓	$30.7K
Annual income after 10y	$37,339,999.80 ✓	$950.29
Total dividends collected	$72.25M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: GSHRF vs MRK ($10,000, DRIP)

Year	GSHRF Portfolio	GSHRF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$29,219	$18,518.52	$11,192	$351.54	+$18.0K → GSHRF
2	$81,832	$50,568.57	$12,524	$392.70	+$69.3K → GSHRF
3	$219,923	$132,362.17	$14,015	$438.65	+$205.9K → GSHRF
4	$567,767	$332,449.13	$15,682	$489.96	+$552.1K → GSHRF
5	$1,409,633	$802,122.93	$17,547	$547.23	+$1.39M → GSHRF
6	$3,369,509	$1,861,201.75	$19,632	$611.16	+$3.35M → GSHRF
7	$7,763,238	$4,157,863.45	$21,963	$682.53	+$7.74M → GSHRF
8	$17,259,544	$8,952,878.98	$24,571	$762.18	+$17.23M → GSHRF
9	$37,069,956	$18,602,243.94	$27,486	$851.08	+$37.04M → GSHRF
10	$77,004,853	$37,339,999.80	$30,745	$950.29	+$76.97M → GSHRF

GSHRF vs MRK: Complete Analysis 2026

GSHRF — Stock

Goldshore Resources Inc., a junior gold development company, engages in the acquisition, exploration, and evaluation of natural resource properties in Canada. It owns the Moss Lake gold project consisting of 3 contiguous mining claims located in Ontario. The company is headquartered in Vancouver, Canada.

Full GSHRF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this GSHRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GSHRF vs SCHD GSHRF vs JEPI GSHRF vs O GSHRF vs KO GSHRF vs MAIN GSHRF vs JNJ GSHRF vs ABBV GSHRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.